| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/15/2004 | US20040009481 Diagnosing, staging, prognosing, monitoring and treating human prostate cancers; marker genes are provided, wherein changes in the levels of expression of one or more of the marker genes is correlated with the presence of prostate cancer |
| 01/15/2004 | US20040009479 Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| 01/15/2004 | US20040009476 Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| 01/15/2004 | US20040009475 Tumor cells to cytotoxic chemotherapeutic agents, especially antimetabolites and agents that damage DNA; excision repair cross-complementing (ERCC1) gene; thymidylate synthase (TS) |
| 01/15/2004 | US20040009473 Kit and process for microbiological for on-site examination of a liquid sample |
| 01/15/2004 | US20040009472 Diagnostic tests to determine whether an asymptomatic subject who is not clinically ill or known to be infected with a virus has been infected with a virus by determining the level of Mx protein or other Type I Interferon-inducible protein |
| 01/15/2004 | US20040009469 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses |
| 01/15/2004 | US20040009468 Allelic variants of HERV-K18, method for analysis thereof and use in the determination of genetic predisposition for disorders involving the HERV-K18 provirus |
| 01/15/2004 | US20040009467 Alternative cellular energy (ACE)-pigments; mineral -containing, auto-fluorescent, pigmented materials that comprise aggregates of very fine chemical structures held together by a Selective Mineral Affinity Force (SMAF) |
| 01/15/2004 | US20040009464 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmacetical compositions containing such compounds |
| 01/15/2004 | US20040009173 Invention provides nucleic acids and proteins capable of modulating leukocyte activation and platelet proliferation; concerns disorders related to dysfunction and dysregulation of leukocyte activation or platelet proliferation |
| 01/15/2004 | US20040009171 Methods for the treatment of carcinoma |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | US20040009124 Detection of drug-resistant human immunodeficiency virus |
| 01/15/2004 | US20040008336 Method and system of determining chamber seasoning condition by optical emission |
| 01/15/2004 | US20040007464 An electric device for transporting material, by applying and controlling an electric potential simultaneously at each different ports, to create differences in potential; use in liquid chromatography |
| 01/15/2004 | US20040007461 Electrical sensor |
| 01/15/2004 | US20040007051 Microscale sensor element and related device and method of manufacture |
| 01/15/2004 | DE20121978U1 Novel chemically modified genomic DNA sequences, useful in the characterization, classification, differentiation, grading, staging, treatment and/or diagnosis of astrocytomas or predisposition to astrocytomas |
| 01/15/2004 | DE20121975U1 Oligonucleotide for diagnosing and treating tumors and cancer especially gliomas, astrocytomas and oligodendromas, comprises chemically modified genomic sequences of genes associated with tumors and cancers |
| 01/15/2004 | DE20121964U1 New nucleic acid, useful for diagnosis and therapy of metabolic disease, solid tumor and cancers, comprises segment of chemically modified genomic sequences of genes associated with metabolism |
| 01/15/2004 | DE20121960U1 New nucleic acid derived from chemically treated metastasis genes, useful for diagnosis of cancers by analysis of cytosine methylation, also for treatment |
| 01/15/2004 | DE10230328A1 Einweg-Probenträger für Massenspektrometrie One-sample support for Mass Spectrometry |
| 01/15/2004 | DE10228785A1 Detektion von toxischen Algen Detection of toxic algae |
| 01/15/2004 | DE10227962A1 Grundkörper für einen Bio-Chip Base for a bio-chip |
| 01/15/2004 | DE10227001A1 Verfahren zum Identifizieren von fungizid wirksamen Verbindungen A method for identifying fungicidally active compounds |
| 01/15/2004 | DE10226420A1 Verfahren zur Behandlung der Artherosklerose A method for the treatment of atherosclerosis |
| 01/15/2004 | DE10022304B4 Verfahren zur Identifizierung, Quantifizierung und Visualisierung von Mikroorganismen Method for the identification, quantification and visualization of microorganisms |
| 01/15/2004 | CA2494508A1 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | CA2493860A1 Marker genes for determining renal toxicity |
| 01/15/2004 | CA2492074A1 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | CA2491947A1 The use of specified tcf target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which tcf/.beta.-catenin/wnt signalling plays a central role |
| 01/15/2004 | CA2491896A1 Monitoring of cells |
| 01/15/2004 | CA2491890A1 A method of studying living cells |
| 01/15/2004 | CA2491889A1 Detection of microorganisms with holographic sensor |
| 01/15/2004 | CA2491847A1 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 01/15/2004 | CA2491690A1 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | CA2491642A1 Screening for anti-ovulatory compounds |
| 01/15/2004 | CA2491637A1 Methods for identifying modulators of mda-7 mediated apoptosis |
| 01/15/2004 | CA2491627A1 Glucose dehydrogenase |
| 01/15/2004 | CA2491591A1 Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design |
| 01/15/2004 | CA2491286A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | CA2491218A1 Caspase 9 activation and uses therefor |
| 01/15/2004 | CA2491143A1 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 01/15/2004 | CA2491064A1 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
| 01/15/2004 | CA2491026A1 Diagnosis of sepsis using mitochondrial nucleic acid assays |
| 01/15/2004 | CA2490934A1 Method for altering fatty acid composition of milk |
| 01/15/2004 | CA2490903A1 Compositions and methods for the detection of human t cell receptor variable family gene expression |
| 01/15/2004 | CA2489562A1 Mitotic kinesin binding site |
| 01/15/2004 | CA2489196A1 Method and test kit for quantitative determination of polynucleotides in a mixture |
| 01/15/2004 | CA2489151A1 Method for enriching and tracking pathologic modified prions-proteins (prpsc) |
| 01/15/2004 | CA2487856A1 Methods for identification of compounds modulating insulin resistance |
| 01/14/2004 | EP1380839A1 Production of spatially defined solid phases for binding assays |
| 01/14/2004 | EP1380655A2 Detection of Shiga toxin- or Shiga-like toxin-producing organisms |
| 01/14/2004 | EP1380654A1 Multiplex PCR primer set for human glucokinase gene amplification |
| 01/14/2004 | EP1380650A1 Conditionally replicating viral vectors and their use |
| 01/14/2004 | EP1380648A2 Recombinant DNAase B derived from streptococcus pyogenes |
| 01/14/2004 | EP1380644A1 The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role |
| 01/14/2004 | EP1380643A1 Process, construct and conjugate for producing multiple nucleic acid copies |
| 01/14/2004 | EP1380642A1 A method for the separation and purification of nucleic acid |
| 01/14/2004 | EP1380594A1 Fibroblast growth factor-10 |
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1380001A2 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |
| 01/14/2004 | EP1379997A2 Predicting metabolic stability of drug molecules |
| 01/14/2004 | EP1379881A2 Method for determining the substrate specificity of an enzymatic activity and a device therefor |
| 01/14/2004 | EP1379880A2 Screening for drugs against disorders associated with schizophrenia |
| 01/14/2004 | EP1379876A2 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase |
| 01/14/2004 | EP1379875A1 Detection of biological pathway components |
| 01/14/2004 | EP1379873A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 01/14/2004 | EP1379872A2 Use of metabolic phenotyping in individualized treatment with amonafide |
| 01/14/2004 | EP1379870A1 A crystal of bacterial core rna polymerase with rifampicin and methods of use thereof |
| 01/14/2004 | EP1379868A2 Transgenic zebrafish models for neurodegenerative diseases |
| 01/14/2004 | EP1379863A2 Apparatus and method for the detection of localised fluctuations of ionic charge by ion sensitive field effect transistors during a chemical reaction |
| 01/14/2004 | EP1379852A1 Multi-format sample processing devices, methods and systems |
| 01/14/2004 | EP1379701A2 Elimination of endogenous porcine retrovirus |
| 01/14/2004 | EP1379700A2 Microarray method for enriching dna fragments from complex mixtures |
| 01/14/2004 | EP1379699A2 Detection of fungal pathogens using the polymerase chain reaction |
| 01/14/2004 | EP1379698A1 Mobility-modified nucleobase polymers and methods of using same |
| 01/14/2004 | EP1379697A1 Diagnostic detection of nucleic acids |
| 01/14/2004 | EP1379696A2 Prognostic methods for breast cancer |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379694A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 01/14/2004 | EP1379693A2 Bio-barcodes based on oligonucleotide-modified particles |
| 01/14/2004 | EP1379692A1 Nucleic acid analysis using non-templated nucleotide addition |
| 01/14/2004 | EP1379691A1 Differentially methylated sequences in pancreatic cancer |
| 01/14/2004 | EP1379690A1 Oligonucleotide chip composition for analyzing hepatitis c virus (hcv) genotype and detecting method thereof |
| 01/14/2004 | EP1379688A2 Polymorphisms in the human cmoat gene and uses thereof |
| 01/14/2004 | EP1379687A2 Detection of rare candida species |
| 01/14/2004 | EP1379686A2 Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates |
| 01/14/2004 | EP1379685A2 Assay for the detection and quantitation of hemimethylation |
| 01/14/2004 | EP1379684A2 Method and system for detecting nucleic acids |
| 01/14/2004 | EP1379683A2 Methods of identification and isolation of polynucleotides containing nucleic acid differences |
| 01/14/2004 | EP1379682A1 Cell isolation method and uses thereof |
| 01/14/2004 | EP1379681A2 Diagnosis by sensing volatile components |
| 01/14/2004 | EP1379680A2 Method for fixing biomolecules onto chemically inert surfaces |
| 01/14/2004 | EP1379679A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379662A2 Sulfatases and methods of use thereof |
| 01/14/2004 | EP1379660A2 Self-replicating rna molecule from hepatitis c virus |